Cita APA

Canyelles, M., Plaza, M., Rotllan, N., Llobet, D., Julve i Gil, J., Mojal, S., . . . Souto, J. C. (2022). TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism.

Citación estilo Chicago

Canyelles, Marina|||0000-0002-0278-5337, et al. TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated With Thrombotic Risk in Patients With Venous Thromboembolism. 2022.

Cita MLA

Canyelles, Marina|||0000-0002-0278-5337, et al. TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated With Thrombotic Risk in Patients With Venous Thromboembolism. 2022.